Dr. Steven Kussick, M.D., PH.D.
What this data tells you about Dr. Kussick
Dr. Steven Kussick is an optician specialist in Seattle, WA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kussick performed 932 Medicare services across 311 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kussick received a total of $12,368 from 2 pharmaceutical and/or device companies across 33 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kussick is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tissue staining for diagnosis, additional An extra laboratory procedure to apply special stains to tissue slides for detailed examination. |
321 | $31 | $136 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
297 | $20 | $72 |
| Flow cytometry, 16 or more markers A laboratory test that uses lasers to analyze cells or DNA using 16 or more different markers. This technique helps identify and characterize specific cell types based on their physical and chemical properties. |
66 | $70 | $310 |
| Manual microscopic genetic analysis of tumor A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes. |
65 | $45 | $170 |
| Tissue staining for diagnosis, initial A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics. |
58 | $41 | $163 |
| Surgical pathology consultation with slide preparation A specialist reviews tissue samples sent by another provider, preparing necessary slides for examination. The specialist then provides a diagnostic report based on this analysis. |
30 | $67 | $177 |
| Flow cytometry DNA or cell analysis, 9-15 markers A laboratory test that uses a laser to analyze cells or DNA using 9 to 15 different markers. This technique helps identify and characterize specific cell types or genetic material. |
22 | $52 | $235 |
| BCR-ABL1 gene translocation test A laboratory test that analyzes DNA to detect the BCR-ABL1 gene translocation, also known as the Philadelphia chromosome. This test is used to identify specific genetic changes associated with certain types of leukemia. |
17 | $161 | $245 |
| Molecular pathology test interpretation A physician reviews and interprets the results of a molecular pathology test to provide a diagnostic report. |
16 | $26 | $35 |
| BCR/ABL1 minor breakpoint translocation analysis A laboratory test that analyzes genetic material to detect specific chromosomal translocations involving the BCR and ABL1 genes at the minor breakpoint cluster region. |
15 | $142 | $245 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
13 | $71 | $110 |
| Genetic sequencing localization, initial procedure This procedure involves the initial process of localizing genetic sequencing. It identifies the specific location of genetic material for further analysis. |
12 | $47 | $133 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
All-time payments by company (2018-2024) ›
Associated products mentioned in payments ›
The majority of payments (53%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kussick is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 11% of WA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kussick experienced with tissue staining for diagnosis, additional?
Does Dr. Kussick receive payments from pharmaceutical companies?
How do Dr. Kussick's costs compare to other opticians in Seattle?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology